Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease

Interleukin (IL)-17 and IL-23 are crucial for mediating gut mucosal inflammation in inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We assessed the relevancy of IL-17 and IL-23 serum levels as potential biomarkers towards severe IBD discrimination and disease-related c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucaciu, Laura A., Ilieș, Maria, Vesa, Ștefan C., Seicean, Radu, Din, Shahida, Iuga, Cristina Adela, Seicean, Andrada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621192/
https://www.ncbi.nlm.nih.gov/pubmed/34834482
http://dx.doi.org/10.3390/jpm11111130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621192/
https://www.ncbi.nlm.nih.gov/pubmed/34834482
http://dx.doi.org/10.3390/jpm11111130

Ejemplares similares